Dominant model | Additive model | ||||||
---|---|---|---|---|---|---|---|
 | 0 copies | 1 or 2 copies |  |  | |||
 | Case/ control | AOR | Case/ control | AOR (95% CI) | p | AOR (95% CI) | p |
SNP1 | 162/245 | 1.00 | 104/196 | 0.64 (0.43-0.94)* | 0.02 | 0.67 (0.50-0.91)* | 0.01 |
ApoE e4 non-carriers | 100/207 | 1.00 | 61/166 | 0.56 (0.35-0.90)* | 0.02 | 0.61 (0.42-0.90)* | 0.01 |
ApoE e4 carriers | 61/37 | 1.00 | 43/29 | 0.82 (0.40-1.70) | 0.60 | 0.81 (0.49-1.34) | 0.28 |
SNP2 | 180/293 | 1.00 | 75/141 | 0.78 (0.51-1.19) | 0.25 | 0.80 (0.56-1.14) | 0.21 |
ApoE e4 non-carriers | 114/249 | 1.00 | 40/118 | 0.72 (0.43-1.20) | 0.21 | 0.72 (0.46-1.12) | 0.14 |
ApoE e4 carriers | 66/43 | 1.00 | 35/22 | 0.89 (0.42-1.91) | 0.77 | 0.99 (0.54-1.83) | 0.59 |
SNP3 | 163/242 | 1.00 | 102/199 | 0.60 (0.41-0.89)* | 0.01 | 0.66 (0.49-0.90)* | < 0.01 |
ApoE e4 non-carriers | 101/204 | 1.00 | 60/169 | 0.55 (0.35-0.88)* | 0.01 | 0.60 (0.41-0.89)* | 0.01 |
ApoE e4 carriers | 61/37 | 1.00 | 42/29 | 0.73 (0.36-1.52) | 0.40 | 0.81 (0.48-1.34) | 0.23 |